P

ProQR Therapeutics NV

D
PRQR
USD
-0.05
(-1.3774%)
Market Closed
13,946.00
Volume
-0.44
EPS
-
Div Yield
-12.276350
P/E
292,415,098.10
Market Cap
Today
-1.3774%
1 Week
3.170%
1 Month
85.492%
6 Months
79.899%
12 Months
163.235%
Year To Date
79.899%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
D
DRNA
(%)
USD
V
VKTX
3.91
(6.02%)
USD
A
AXSM
1.49
(1.6708%)
USD
C
CRBP
-0.36
(-1.9027%)
USD
G
GLPG
0.465
(1.7222%)
USD
S
SAGE
0.385
(6.4815%)
USD
C
CYTK
0.16
(0.2875%)
USD
NVS
NVS
0.23
(0.2153%)
USD

Title:
ProQR Therapeutics NV

Sector:
Healthcare
Industry:
Biotechnology
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Do you need help or have a question?
Contact Us